Page last updated: 2024-08-23

1-deoxynojirimycin and Degenerative Diseases, Central Nervous System

1-deoxynojirimycin has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Keage, M; Lewis, C; Schubiger, D; Velakoulis, D; Vogel, AP; Walterfang, M; Watanabe, M1
Anderson, K; Griffiths, TD; Lad, M; Thomas, RH1

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Degenerative Diseases, Central Nervous System

ArticleYear
Characterization of Dysphagia and Longitudinal Changes in Swallowing Function in Adults with Niemann-Pick Disease Type C Treated with Miglustat.
    Dysphagia, 2021, Volume: 36, Issue:3

    Topics: 1-Deoxynojirimycin; Adolescent; Adult; Deglutition; Deglutition Disorders; Enzyme Inhibitors; Humans; Neurodegenerative Diseases; Niemann-Pick Disease, Type C; Retrospective Studies

2021
Niemann-Pick type C: contemporary diagnosis and treatment of a classical disorder.
    Practical neurology, 2019, Volume: 19, Issue:5

    Topics: 1-Deoxynojirimycin; Adult; Female; Humans; Lysosomal Storage Diseases; Neurodegenerative Diseases; Niemann-Pick Disease, Type C; Skin; Treatment Outcome

2019